Skip to content

Deep Lens (acquired by Paradigm) vs Virgo

Deep Lens (acquired by Paradigm) logo

Deep Lens (acquired by Paradigm)

Accelerating clinical trial matching in oncology

5 employees · est. 2017 · Columbus, United States

VS
Virgo logo

Virgo

Accelerate clinical trials with AI for endoscopy

33 employees · est. 2017 · San Francisco, United States

Virgo is the larger of the two.

Side-by-Side Comparison

Deep Lens (acquired by Paradigm) Virgo
Founded
2017 2017
Headquarters
Columbus, United States San Francisco, United States
Employees
5 33 larger
Industry
AI, Health Care, Life Sciences AI, Computer Vision, Medical Devices
Funding Stage
Series A Venture round
Total Funding
$17.20M $9.61M
Funding Rounds
2 5
Services
Not tracked yet Endoscopy Video Capture and Recording, AI-powered Video Analysis, Patient Recruitment Analytics, Clinical Trial Site Selection
Target Customers
Not tracked yet Gastroenterologists, Pharmaceutical Researchers, Clinical Trial Sites, Medical Systems, Healthcare Providers, Researchers
Taxonomy
Digital HealthcareClinical TrialsOncologyAI-driven PlatformCancer Patient RecruitmentDigital Pathology Workflow +8 AI In HealthcareEndoscopic MedicineVideo AnalysisCloud Video ManagementClinical Trials AccelerationPatient Recruitment +8
Website
deeplens.ai virgosvs.com
Deep Lens (acquired by Paradigm) logo

About Deep Lens (acquired by Paradigm)

Deep Lens, with the slogan "Accelerating clinical trial matching in oncology," is a digital healthcare company that was established in 2017 and is headquartered in the United States. The company focuses on leveraging AI, machine learning, and life sciences to expedite the recruitment of suitable can...

Virgo logo

About Virgo

Virgo Surgical Video Solutions, headquartered in the United States, is at the forefront of leveraging cutting-edge technology to enhance the field of endoscopic medicine. Established in 2017, Virgo specializes in a cloud-based video capture and AI-driven analysis platform, empowering healthcare prov...

Also comparing in this category

Comparing more than these two?

Get Deep Lens (acquired by Paradigm), Virgo and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Deep Lens (acquired by Paradigm) compare?

A PDF of Deep Lens (acquired by Paradigm) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Deep Lens (acquired by Paradigm) was founded in 2017, based in Columbus, United States, with 5 employees. Deep Lens, with the slogan "Accelerating clinical trial matching in oncology," is a digital healthcare company that was established in 2017 and is headquartered in the United States. The company focus. Virgo was founded in 2017, based in San Francisco, United States, with 33 employees. Virgo Surgical Video Solutions, headquartered in the United States, is at the forefront of leveraging cutting-edge technology to enhance the field of endoscopic medicine. Established in 2017, Virgo sp.
Deep Lens (acquired by Paradigm) has raised $17.20M and Virgo $9.61M. Latest stage: Deep Lens (acquired by Paradigm) Series A, Virgo Venture round.
Both work in AI and Machine Learning.

Compare Deep Lens (acquired by Paradigm) with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deep Lens (acquired by Paradigm) on 11 Sep 2024, and Virgo on 4 Aug 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout